Center of Excellence in Stem Cell Genomics

Overview

Salk Institute for Biological Studies - Center of Excellence in Stem Cell Genomics - Overview

Overview


Center of Excellence in Stem Cell Genomics

The Center of Excellence in Stem Cell Genomics, led by researchers at the Salk Institute and Stanford University, was created through a $40 million award by California’s stem cell agency, the California Institute for Regenerative Medicine.

The center brings together experts and investigators from seven major California institutions to focus on bridging the fields of genomics — the study of the complete genetic make-up of a cell or organism — with cutting-edge stem cell research.

The center’s goal is to use these tools to gain a deeper understanding of the disease processes in cancer, diabetes, endocrine disorders, heart disease and mental health, and ultimately to find safer and more effective ways of using stem cells in medical research and therapy.

Salk Professor Joseph Ecker, holder of the Salk International Council Chair in Genetics, is co-director of the new center along with Michael Snyder, a professor and chair of genetics at Stanford. These two leaders in the field of genomics have extensive experience working on large-scale projects and have been working in national and international consortia for generating and distributing genomics data. This Center of Excellence also includes the experience of Josh Stuart and David Haussler, leaders in data coordination and management, from the University of California, Santa Cruz (UCSC), extending collaborative relationships that have been developed over the past decade.

Our Vision

Our vision is to advance Stem Cell research in the State of California by establishing the Center of Excellence in Stem Cell Genomics (CESCG). The Center is generating banks of data and iPS cell lines that are valuable resources to the entire CIRM community and provide important insights into stem cell research. It also serves as an important focal point for collaborative projects with other CIRM investigators and makes genomics capabilities available to the entire regenerative medicine community.

Support Salk Research

Donate